Clinical trials
Keloid trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 8 |
| Unknown status | 7 |
| Recruiting | 5 |
| Withdrawn | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tirgan, Michael H., M.D. | 8 |
| Renovo | 3 |
| University of Michigan | 3 |
| Capstone Therapeutics | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| NYU Langone Health | 2 |
| Northwestern University | 2 |
| The Center for Clinical and Cosmetic Research | 2 |
| University of Miami | 2 |
| AiViva BioPharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Keloid | 55 |
| Cicatrix | 17 |
| Cicatrix, Hypertrophic | 13 |
| Fibrosis | 4 |
| Scleroderma, Localized | 4 |
| Surgical Wound | 4 |
| Granuloma Annulare | 3 |
| Scleroderma, Diffuse | 3 |
| Acne Keloid | 2 |
| Acne Vulgaris | 1 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.